arrow
D

David M. Thomas

Garvan Institute of Medical Research
H指数:76
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature

临床诊断戈林综合征患者中低水平PTCH1嵌合现象的解读挑战:病例系列分析及文献综述

2026-03-010
PRE
A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations

早期分化的人类基因组变异目录揭示了独特的科伊桑人群

2026-02-100
PRE
Implementation of precision medicine in treating non-communicable diseases: a systematic review

在非传染性疾病治疗中实施精准医学:一项系统综述

2025-10-280
OAAI
Precision Oncology: A Global Perspective on Implementation and Policy Development
2025-01-010
OA
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
2024-09-091
OAAI
Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)

症状和功能负担对胰腺导管腺癌(PDAC)生存期的影响

2024-09-010
PRE
Phase II trial of vemurafenib (VEM) and cobimetinib (COB) in BRAF V600-mutated solid tumours and first-line (1L) non-small cell lung cancer (NSCLC): Australian molecular screening and therapeutics (MoST) substudy 12

vemurafenib(VEM)和cobimetinib(COB)在BRAF V600突变实体瘤和一线(1L)非小细胞肺癌(NSCLC)中的II期试验:澳大利亚分子筛查和治疗(MoST)子研究12

2024-09-010
PRE
Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients
2024-03-220
PRE